Archive for December 26, 2017

Nucala Approved for EGPA/CSS Treatment

GlaxoSmithKline (GSK) achieves approval for Nucala (mepolizumab) for the treatment of eosinophilic granulomatosis with polyangiitis (EGPA) for adults in the US December 13, 2017:  GSK announced that the US Food and more »


Read More